251
Participants
Start Date
March 31, 2015
Primary Completion Date
July 31, 2016
Study Completion Date
July 31, 2016
ALX-0061
Placebo
Tocilizumab
Investigator Site 1, Skopje
Investigator Site 2, Skopje
Investigator Site, Brussels
Investigator Site, Chisinau
Investigator Site, Szikszó
Investigator Site, Liège
Investigator site, Gyula
Investigator Site, Baja
Investigator Site, Székesfehérvar
Investigator Site, Veszprém
Investigator Site, Ghent
Investigator Site, Szombathely
Investigator Site, New York
Investigator Site, Lublin
Investigator Site, Madrid
Investigator Site, Charleston
Investigator Site, Stockbridge
Investigator Site, Orlando
Investigator site, Hialeah
Investigator Site, Homestead
Investigator Site, Birmingham
Investigator Site, Memphis
Investigator Site, Santander
Investigator SIte, Poznan
Investigator site, Overland Park
Investigator Site, Ostrava
Investigator Site, Mesquite
Investigator Site 2, Elblag
Investigator Site, Torun
Investigator Site, Albuquerque
Investigator site, Los Angeles
Investigator Site, Los Angeles
Investigator Site, La Palma
Investigator Site, Hemet
Investigator site, Ventura
Investigator Site, Sochaczew
Investigator Site, Brno
Investigator Site, Worcester
Investigator Site, Burgas
Investigator Site, Pleven
Investigator Site 1, Plovdiv
Investigator Site 2, Plovdiv
Investigator Site 1, Rousse
Investigator Site 2, Rousse
Investigator Site, Sofia
Investigator Site, Olomouc
Investigator Site 1, Prague
Investigator Site 2, Prague
Investigator Site, Zlín
Investigator Site, Berlin
Investigator Site, Frankfurt
Investigator Site, Hamburg
Investigator Site, Budapest
Investigator Site, Esztergom
Investigator Site, Culiacán
Investigator Site, León
Investigator Site 1, Mexico City
Investigator Site 2, Mexico City
Investigator Site, Mexico City
Investigator Site 1, Monterrey
Investigator Site 2, Monterrey
Investigator Site, Chisinau
Investigator Site, Bydgoszcz
Investigator Site, Elblag
Investigator Site, Gdynia
Investigator Site, Bucharest
Investigator Site, Oradea
Investigator Site, Timișoara
Investigator Site 1, Belgrade
Investigator Site 2, Belgrade
Investigator Site 3, Belgrade
Investigator Site, Niška Banja
Investigator Site, Córdoba
Investigator Site 2, Santander
Investigator Site 1, Santiago de Compostela
Investigator Site 2, Santiago de Compostela
Investigator Site, Tbilisi
Investigator Site 1, Tbilisi
Investigator Site 2, Tbilisi
Investigator Site, Tbilisi
Investigator Site, Tbilisi
Investigator Site, Grodzisk Mazowiecki
Investigator Site, Warsaw
Ablynx, a Sanofi company
INDUSTRY